Development of an efficient method for producing fully human monoclonal antibodies for clinical application
Nature knows best: fully human antibodies take the therapeutic lead
Monoclonal antibody - Wikipedia
Native™ Human Antibody Discovery Service - Creative Biolabs
The safety of therapeutic monoclonal antibodies: Implications for cardiovascular disease and targeting the PCSK9 pathway - Atherosclerosis
The Overview of Recombinant Antibody-CUSABIO
How are mouse monoclonal antibodies humanized: current approaches and limitations
Fully human antibody production technology - Kyowa Kirin
Fully Human Antibody Discovery by Transgenic Mice
Single B cell technologies for monoclonal antibody discovery: Trends in Immunology
The Advent of Therapeutic Antibodies - Evidentic GmbH
Broadly neutralizing antibodies against influenza A viruses, Fully human, FI6, MEDI8852
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen | Nature Protocols
Transgenic Mice That Produce Fully Humanized Antibodies -- Abgenix Granted Patent
Pattern and Trend of Therapeutic Antibody Discovery – Creative Biolabs rAb Blog
Humanization | Absolute Antibody
Monoclonal Antibodies - Magic bullets or a shot in the dark - Drug Discovery World (DDW)
Development of an efficient method for producing fully human monoclonal antibodies for clinical application
Humanized antibody - Wikipedia
Fully Human Monoclonal Antibody Services | ProMab Biotechnologies
Novel Mice Models Produce Fully-Human Antibodies
Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care? - Abstract - Europe PMC
Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody - International Journal of Radiation Oncology, Biology, Physics
Molecular Insights into Fully Human and Humanized Monoclonal Antibodies What are the Differences and Should Dermatologists Care? – JCAD | The Journal of Clinical and Aesthetic Dermatology
Evolution and Emergence of Therapeutic Monoclonal Antibodies | Circulation
Development of a novel, fully human, anti-PCSK9 antibody with potent hypolipidemic activity by utilizing phage display-based strategy - eBioMedicine
